Amgen’s Weight-Loss Results Are ‘A Bit Underwhelming,’ Says Lilly Executive
Investor's Business DailyAmgen stock slouched Wednesday after a Lilly exec called the company’s early-stage test results for a weight-loss drug “a bit underwhelming.”
The post Amgen's Weight-Loss Results Are 'A Bit Underwhelming,' Says Lilly Executive appeared f…